US 12083224
Lipid particles for nucleic acid delivery
granted A61KA61K2039/55555A61K31/7105
Quick answer
US patent 12083224 (Lipid particles for nucleic acid delivery) held by ARCTURUS THERAPEUTICS, INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- ARCTURUS THERAPEUTICS, INC.
- Grant date
- Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/55555, A61K31/7105, A61K31/711, A61K39/12